The Chicago Entrepreneur

FDA approves Novo Nordisk’s Ozempic to treat chronic kidney disease in those with diabetes, expanding its use

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.

Editorial Team

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Starbucks is about to report earnings. Here’s what to expect
Next post Mystery around top-ranked Rockefeller book grows as university publisher denies involvement